Treatment of Periorbital Dermatitis
Topical calcineurin inhibitors are the first-line therapy for periorbital dermatitis, particularly tacrolimus ointment for adults and pimecrolimus for children. 1, 2
Diagnosis and Classification
- Periorbital dermatitis presents as erythematous papules, pustules, and papulovesicles around the eyes, often with significant discomfort due to its visible location 1
- Common causes include allergic contact dermatitis (32-44%), atopic eczema (14-25%), airborne contact dermatitis (2-10%), and irritant contact dermatitis (8-9%) 1
- Less common causes include periorbital rosacea, allergic conjunctivitis, or psoriasis vulgaris 1
- Risk factors include female gender, atopic skin diathesis, and age over 40 years 1
First-Line Treatment
For atopic eczema and other forms of periorbital dermatitis:
For allergic contact dermatitis:
Second-Line Treatments
For moderate-to-severe cases:
- Short-term topical corticosteroids (maximum 8 weeks) such as preservative-free dexamethasone 0.1% 3
- Triamcinolone cream shows lower rates of refractory disease (less than 30%) compared to hydrocortisone (over 80% refractory cases) 5
- Transition to steroid-sparing agents (tacrolimus, pimecrolimus) as soon as possible to avoid rebound 3, 4
For periorbital hyperpigmentation:
Management Principles
Avoid potential irritants:
Supportive measures:
Special Considerations
For eyelid involvement:
For refractory cases:
Treatment Duration and Follow-up
- Most treatments require multiple sessions over weeks to months 2
- Monitor for potential side effects of topical corticosteroids (glaucoma, cataracts) with baseline and periodic IOP measurements if used 3
- For calcineurin inhibitors, monitor for potential development of skin cancer or lymphoma (rare side effect) 3
Common Pitfalls
- Overuse of topical corticosteroids can worsen the condition or cause rebound dermatitis 6, 4
- Failure to identify and eliminate contact allergens will result in persistent symptoms 1
- Hydrocortisone has high rates of refractory disease (over 80%) and should be avoided 5
- Greasy topical products should be avoided as they can promote superinfection 3